The global enteric disease testing market is estimated to grow at a CAGR of 5.94% during the forecast period. The market size is expected to rise to USD 41.06 billion by 2029 from USD 30.77 billion in 2024.
The body may lose fluids and essential nutrients due to intestinal illnesses. Anorexia, nausea, vomiting, and stomach discomfort are common symptoms of enteric disorders. Enteric diseases, which include parasites, viruses, and bacteria, are brought on by foreign antigens. The most common infections causing intestinal diseases include Salmonella, Shigella, rotavirus, norovirus, E. coli, and Vibro Cholerae. The enteric disease mainly occurs through consuming contaminated food and can be transmitted from one infected person to another. The testing of enteric illnesses is generally carried out by using cultures and observing the samples of the patient's blood, bone marrow, tissue, etc., for any pathogen. It is essential to perform enteric disease testing to cure the diseases caused by these foreign invaders and exercise caution.
The demand for early diagnosis of the enteric disease is anticipated to increase due to the increasing prevalence of enteric infections and the cost-effectiveness of technologically enhanced diagnostic equipment leading to a rise in the enteric disease testing market. A classic diagnostic method, like the culture method, required experienced personnel and was arduous and time-consuming. Therefore, Over the past ten years, the market for testing enteric disorders has undergone a revolution thanks to the advent of molecular diagnostics and other diagnostic technologies.
Increasing rates of death, especially in developing countries, push market growth. For example, 90% of deaths connected to diarrhea are also caused by a lack of access to safe drinking water and basic sanitary facilities. Additionally, 90% of typhoid-related mortality occurs in Asia. Furthermore, growing demand for early detection of various illnesses, increased gastrointestinal disease in developing countries, inadequate laboratory conditions, and shared knowledge are all leading to a spike in cases of enteric infection, pushing the need for a testing market.
Enteric disease testing is becoming increasingly important as people's preferences for convenience foods change, and they prefer packaged items with preservatives to increase the shelf life of packaged goods. However, these packages of goods can cause problems like food poisoning. Additionally, the post covid world is exceptionally cautious about food safety, and the government initiatives and key market players' investments towards improving healthcare facilities are expected to drive the market growth.
Factors such as the rise in the incidence of undiscovered gastrointestinal illnesses and the lack of patient awareness in emerging countries, along with the high cost of labor and labor-intensive equipment, as well as the necessity for sophisticated laboratory conditions for clinical diagnoses, are primarily hampering the growth of the enteric disease testing market. In addition, the absence of reimbursement legislation in developing nations like China and India, along with the weak regulation of pathogen testing in emerging economies.
The E-coli segment is expected to lead the enteric disease testing market during the forecast period due to the prevalence of the diseases caused by e-coli infections. In addition, E-coli is the most prominent cause of enteric diseases, especially in children.
Based on technology, the rapid segment is anticipated to lead the market during the forecast period. Therefore, the rapid technology sector is also leading the market. This is because the food industry uses rapid technology to track the number, type, and metabolites of microorganisms that result in food spoilage, preservation, fermentation, safety, and foodborne pathogens.
Throughout the projected period, the market is anticipated to be dominated by the food category. Government and public health institutions now closely monitor food quality and move fast to identify, contain, and eradicate outbreaks' causes because of the growth of the food trade.
Geographically, the North American region is forecasted to showcase significant domination among all the regions in the global market during the forecast period owing to the high consumer awareness of nutritious meals and nutrition, rising typhoid prevalence, expensive goods, a crowded market, and a focus on identifying, monitoring, and preventing foodborne illnesses along with the prevalence of packages and canned food consumptions in the countries like the U.S. and Canada. On the other hand, the European market is also fast growing due to a sizable elderly population, substantial levels of technology adoption, supportive government measures, and collaborations and mergers amongst enterprises.
The market in Asia-Pacific and Latin America are expected to be the fastest growing due to the growing public knowledge of testing and infections, the population living in metropolitan areas with gastrointestinal disorders, biomedical research accelerating R&D in the detection and treatment of infectious diseases, and consumer demand for higher-quality healthcare services.
Some of the notable players in the global enteric disease testing market are Diasorin, BioMerieux, Quest Diagnostics, Meridian Biosciences, Bio-Rad Laboratories, B.D.B.D., Alere Inc, Cepheid, Biomerica Inc, Coris Bioconcept, S.G.S. S.A., Intertek Group Plc, Bureau Veritas, A.L.S. Limited, TUV SUV
By Pathogen Tested
Campylobacter
By Technology
Rapid
By End-User
Food
By Region
Frequently Asked Questions
The global enteric disease testing market size is projected to be valued at USD 2.8 billion by 2027.
Yes, we have studied and included the COVID-19 impact on the global enteric disease testing market in this report.
Geographically, the North American region led the enteric disease testing market worldwide in 2021.
Diasorin, BioMerieux, Quest Diagnostics, Meridian Biosciences, Bio-Rad Laboratories, B.D.B.D., Alere Inc, Cepheid, Biomerica Inc, Coris Bioconcept, S.G.S. S.A., Intertek Group Plc, Bureau Veritas, A.L.S. Limited, TUV SUD are a few of the noteworthy players in the enteric disease testing market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region